======= PHF15 ======= == Gene Information == * **Official Symbol**: JADE2 * **Official Name**: jade family PHD finger 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23338|23338]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQC1|Q9NQC1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PHF15&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHF15|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610515|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the HBO1 complex which has a histone H4- specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo (PubMed:16387653). Acts as a E3 ubiquitin- protein ligase mediating the ubiquitination and subsequent proteasomal degradation of target protein histone demethylase KDM1A (PubMed:25018020). Also acts as a ubiquitin ligase E3 toward itself. Positive regulator of neurogenesis (By similarity). {ECO:0000250|UniProtKB:Q6ZQF7, ECO:0000269|PubMed:16387653}. |PHD| |EPL1| |histone H4-K12 acetylation| |histone H4-K8 acetylation| |histone H4-K5 acetylation| |histone H4-K16 acetylation| |histone acetyltransferase complex| |histone H3 acetylation| |histone H4 acetylation| |transferase activity| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |protein acylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |protein ubiquitination| |chromatin organization| |protein modification by small protein conjugation| |peptidyl-amino acid modification| |protein modification by small protein conjugation or removal| |chromosome organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-2.26| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|-2.03| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-2| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-1.87| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|-1.86| |[[:results:exp292|Menadione 5μM R06 exp292]]|-1.8| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.74| |[[:results:exp209|Deguelin 0.15μM R05 exp209]]|-1.71| |[[:results:exp136|MS094 2μM R03 exp136]]|1.72| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.08| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|3.04| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11192 * **Expression level (log2 read counts)**: 5.14 {{:chemogenomics:nalm6 dist.png?nolink |}}